APYX: Apyx Medical Corp Financial Statements
Balance sheet, income statement, and cash flow statements for Apyx Medical Corp (APYX).
$54.74M Market Cap.
APYX Market Cap. (MRY)
APYX Shares Outstanding (MRY)
APYX Assets (MRY)
Total Assets
$64.84M
Total Liabilities
$50.51M
Total Investments
$0
APYX Income (MRY)
Revenue
$48.10M
Net Income
-$23.46M
Operating Expense
$48.20M
APYX Cash Flow (MRY)
CF Operations
-$18.05M
CF Investing
-$722.00K
CF Financing
$6.75M
APYX Balance Sheet (MRY)
Metric | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
Total Assets | $64,842,000 (-18.17%) | $79,240,000 (53.05%) | $51,775,000 (-24.66%) | $68,721,000 (-7.27%) |
Assets Current | $56,440,000 (-19.79%) | $70,362,000 (63.74%) | $42,972,000 (-29.25%) | $60,737,000 (-8.10%) |
Assets Non-Current | $8,402,000 (-5.36%) | $8,878,000 (0.85%) | $8,803,000 (10.26%) | $7,984,000 (-0.47%) |
Goodwill & Intangible Assets | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Shareholders Equity | $14,210,000 (-46.78%) | $26,701,000 (-28.95%) | $37,582,000 (-30.02%) | $53,704,000 (-15.72%) |
Property Plant & Equipment Net | $6,738,000 (-5.71%) | $7,146,000 (-5.80%) | $7,586,000 (10.36%) | $6,874,000 (-4.73%) |
Cash & Equivalents | $31,741,000 (-27.29%) | $43,652,000 (328.30%) | $10,192,000 (-66.98%) | $30,870,000 (-26.35%) |
Accumulated Other Comprehensive Income | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Deferred Revenue | $1,118,000 (-10.27%) | $1,246,000 (-11.51%) | $1,408,000 (6.42%) | $1,323,000 (113.04%) |
Total Investments | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Investments Current | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Investments Non-Current | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Inventory | $7,564,000 (-23.77%) | $9,923,000 (-15.89%) | $11,797,000 (74.05%) | $6,778,000 (67.32%) |
Trade & Non-Trade Receivables | $15,480,000 (10.15%) | $14,053,000 (31.32%) | $10,701,000 (-20.86%) | $13,521,000 (39.77%) |
Trade & Non-Trade Payables | $2,615,000 (-3.58%) | $2,712,000 (1.61%) | $2,669,000 (1.44%) | $2,631,000 (74.12%) |
Accumulated Retained Earnings (Deficit) | -$77,911,000 (-43.09%) | -$54,448,000 (-52.37%) | -$35,735,000 (-184.72%) | -$12,551,000 (-578.86%) |
Tax Assets | $0 (0%) | $0 (0%) | $7,545,000 (-1.27%) | $7,642,000 (-0.16%) |
Tax Liabilities | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Total Debt | $38,764,000 (0.68%) | $38,501,000 (4736.81%) | $796,000 (160.98%) | $305,000 (-54.88%) |
Debt Current | $355,000 (-3.27%) | $367,000 (45.06%) | $253,000 (-11.85%) | $287,000 (-21.15%) |
Debt Non-Current | $38,409,000 (0.72%) | $38,134,000 (6922.84%) | $543,000 (2916.67%) | $18,000 (-94.23%) |
Total Liabilities | $50,507,000 (-3.46%) | $52,318,000 (274.18%) | $13,982,000 (-4.96%) | $14,712,000 (43.50%) |
Liabilities Current | $10,721,000 (-15.85%) | $12,740,000 (7.51%) | $11,850,000 (-10.26%) | $13,205,000 (44.27%) |
Liabilities Non-Current | $39,786,000 (0.53%) | $39,578,000 (1756.38%) | $2,132,000 (41.47%) | $1,507,000 (37.12%) |
APYX Income Statement (MRY)
Metric | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
Revenues | $48,102,000 (-8.11%) | $52,349,000 (17.61%) | $44,510,000 (-8.26%) | $48,517,000 (75.08%) |
Cost of Revenue | $18,742,000 (0.82%) | $18,590,000 (20.88%) | $15,379,000 (3.10%) | $14,916,000 (46.14%) |
Selling General & Administrative Expense | $43,125,000 (-11.75%) | $48,866,000 (1.49%) | $48,149,000 (10.11%) | $43,728,000 (29.88%) |
Research & Development Expense | $5,080,000 (4.87%) | $4,844,000 (6.60%) | $4,544,000 (5.16%) | $4,321,000 (10.23%) |
Operating Expenses | $48,205,000 (-10.25%) | $53,710,000 (1.93%) | $52,693,000 (9.67%) | $48,049,000 (27.83%) |
Interest Expense | $5,907,000 (138.38%) | $2,478,000 (16420.00%) | $15,000 (50.00%) | $10,000 (-78.26%) |
Income Tax Expense | $252,000 (110.36%) | -$2,432,000 (-762.67%) | $367,000 (-3.42%) | $380,000 (105.06%) |
Net Loss Income from Discontinued Operations | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Consolidated Income | -$23,559,000 (-24.98%) | -$18,850,000 (19.02%) | -$23,278,000 (-53.14%) | -$15,200,000 (-27.67%) |
Net Income to Non-Controlling Interests | -$96,000 (29.93%) | -$137,000 (-45.74%) | -$94,000 (-235.71%) | -$28,000 (-180.00%) |
Net Income | -$23,463,000 (-25.38%) | -$18,713,000 (19.28%) | -$23,184,000 (-52.81%) | -$15,172,000 (-27.54%) |
Preferred Dividends Income Statement Impact | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Net Income Common Stock | -$23,463,000 (-25.38%) | -$18,713,000 (19.28%) | -$23,184,000 (-52.81%) | -$15,172,000 (-27.54%) |
Weighted Average Shares | $35,542,000 (2.66%) | $34,622,000 (0.31%) | $34,516,000 (0.54%) | $34,332,000 (0.35%) |
Weighted Average Shares Diluted | $35,542,000 (2.66%) | $34,622,000 (0.31%) | $34,516,000 (0.54%) | $34,332,000 (0.35%) |
Earning Before Interest & Taxes (EBIT) | -$17,304,000 (7.30%) | -$18,667,000 (18.13%) | -$22,802,000 (-54.26%) | -$14,782,000 (23.62%) |
Gross Profit | $29,360,000 (-13.03%) | $33,759,000 (15.89%) | $29,131,000 (-13.30%) | $33,601,000 (91.96%) |
Operating Income | -$18,845,000 (5.54%) | -$19,951,000 (15.33%) | -$23,562,000 (-63.08%) | -$14,448,000 (28.06%) |
APYX Cash Flow Statement (MRY)
Metric | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
Net Cash Flow from Investing | -$722,000 (-110.72%) | $6,734,000 (766.73%) | -$1,010,000 (-39.70%) | -$723,000 (-24.44%) |
Net Cash Flow from Financing | $6,745,000 (-79.03%) | $32,166,000 (14723.04%) | $217,000 (804.17%) | $24,000 (132.88%) |
Net Cash Flow from Operations | -$18,047,000 (-243.82%) | -$5,249,000 (74.12%) | -$20,280,000 (-94.09%) | -$10,449,000 (34.96%) |
Net Cash Flow / Change in Cash & Cash Equivalents | -$11,911,000 (-135.60%) | $33,460,000 (261.81%) | -$20,678,000 (-87.22%) | -$11,045,000 (34.63%) |
Net Cash Flow - Business Acquisitions and Disposals | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Net Cash Flow - Investment Acquisitions and Disposals | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Capital Expenditure | -$722,000 (-110.72%) | $6,734,000 (766.73%) | -$1,010,000 (-39.70%) | -$723,000 (-24.44%) |
Issuance (Repayment) of Debt Securities | -$20,000 (-100.06%) | $31,933,000 (21676.35%) | -$148,000 (37.82%) | -$238,000 (35.50%) |
Issuance (Purchase) of Equity Shares | $7,000,000 (8039.53%) | $86,000 (-76.44%) | $365,000 (444.78%) | $67,000 (-54.73%) |
Payment of Dividends & Other Cash Distributions | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Effect of Exchange Rate Changes on Cash | $113,000 (159.16%) | -$191,000 (-148.35%) | $395,000 (283.50%) | $103,000 (158.19%) |
Share Based Compensation | $4,013,000 (-21.53%) | $5,114,000 (-23.64%) | $6,697,000 (31.62%) | $5,088,000 (20.86%) |
Depreciation Amortization & Accretion | $711,000 (-8.73%) | $779,000 (-12.47%) | $890,000 (-1.44%) | $903,000 (1.80%) |
APYX Financial Metrics (MRY)
Metric | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
Gross Margin | 61.00% (-5.43%) | 64.50% (-1.38%) | 65.40% (-5.63%) | 69.30% (9.65%) |
Profit Margin | -48.80% (-36.69%) | -35.70% (31.48%) | -52.10% (-66.45%) | -31.30% (27.04%) |
EBITDA Margin | -34.50% (-0.88%) | -34.20% (30.49%) | -49.20% (-72.03%) | -28.60% (57.06%) |
Return on Average Equity (ROAE) | -155.80% (-176.24%) | -56.40% (-6.42%) | -53.00% (-97.03%) | -26.90% (-50.28%) |
Return on Average Assets (ROAA) | -35.90% (-23.79%) | -29.00% (28.22%) | -40.40% (-84.47%) | -21.90% (-42.21%) |
Return on Sales (ROS) | -36.00% (-0.84%) | -35.70% (30.27%) | -51.20% (-67.87%) | -30.50% (56.30%) |
Return on Invested Capital (ROIC) | -28.20% (34.42%) | -43.00% (45.84%) | -79.40% (-31.02%) | -60.60% (28.45%) |
Dividend Yield | 0% (0%) | 0% (0%) | 0% (0%) | 0% (0%) |
Price to Earnings Ratio (P/E) | -2.39 (50.66%) | -4.85 (-38.91%) | -3.49 (88.01%) | -29.14 (-41.64%) |
Price to Sales Ratio (P/S) | 1.17 (-32.66%) | 1.73 (-4.52%) | 1.81 (-79.99%) | 9.07 (2.06%) |
Price to Book Ratio (P/B) | 3.85 (13.33%) | 3.4 (57.80%) | 2.15 (-73.73%) | 8.2 (111.67%) |
Debt to Equity Ratio (D/E) | 3.55 (81.42%) | 1.96 (426.61%) | 0.37 (35.77%) | 0.27 (70.19%) |
Earnings Per Share (EPS) | -0.66 (-22.22%) | -0.54 (19.40%) | -0.67 (-52.27%) | -0.44 (-25.71%) |
Sales Per Share (SPS) | 1.35 (-10.52%) | 1.51 (17.21%) | 1.29 (-8.70%) | 1.41 (74.44%) |
Free Cash Flow Per Share (FCFPS) | -0.53 (-1327.91%) | 0.04 (106.97%) | -0.62 (-89.85%) | -0.33 (33.26%) |
Book Value Per Share (BVPS) | 0.4 (-48.12%) | 0.77 (-29.20%) | 1.09 (-30.37%) | 1.56 (-16.05%) |
Tangible Assets Book Value Per Share (TABVPS) | 1.82 (-20.31%) | 2.29 (52.60%) | 1.5 (-25.07%) | 2 (-7.57%) |
Enterprise Value Over EBIT (EV/EBIT) | -4 (0.00%) | -4 (-33.33%) | -3 (89.29%) | -28 (-154.55%) |
Enterprise Value Over EBITDA (EV/EBITDA) | -3.95 (14.85%) | -4.64 (-51.91%) | -3.06 (89.65%) | -29.52 (-166.90%) |
Asset Turnover | 0.73 (-9.48%) | 0.81 (4.64%) | 0.78 (10.86%) | 0.7 (95.53%) |
Current Ratio | 5.26 (-4.69%) | 5.52 (52.32%) | 3.63 (-21.17%) | 4.6 (-36.29%) |
Dividends | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Free Cash Flow (FCF) | -$18,769,000 (-1363.91%) | $1,485,000 (106.98%) | -$21,290,000 (-90.57%) | -$11,172,000 (32.89%) |
Enterprise Value (EV) | $65,571,340 (-21.02%) | $83,021,900 (24.02%) | $66,939,903 (-83.66%) | $409,783,875 (100.61%) |
Earnings Before Tax (EBT) | -$23,211,000 (-9.77%) | -$21,145,000 (7.33%) | -$22,817,000 (-54.25%) | -$14,792,000 (23.75%) |
Earnings Before Interest Taxes & Depreciation Amortization (EBITDA) | -$16,593,000 (7.24%) | -$17,888,000 (18.36%) | -$21,912,000 (-57.88%) | -$13,879,000 (24.84%) |
Invested Capital | $61,144,000 (-0.33%) | $61,349,000 (100.95%) | $30,529,000 (22.36%) | $24,951,000 (5.19%) |
Working Capital | $45,719,000 (-20.66%) | $57,622,000 (85.15%) | $31,122,000 (-34.52%) | $47,532,000 (-16.52%) |
Tangible Asset Value | $64,842,000 (-18.17%) | $79,240,000 (53.05%) | $51,775,000 (-24.66%) | $68,721,000 (-7.27%) |
Market Capitalization | $54,737,340 (-39.69%) | $90,766,900 (12.11%) | $80,958,903 (-81.61%) | $440,286,875 (78.41%) |
Average Equity | $15,062,750 (-54.60%) | $33,174,250 (-24.19%) | $43,759,500 (-22.36%) | $56,361,250 (-14.98%) |
Average Assets | $65,417,000 (1.46%) | $64,474,750 (12.37%) | $57,377,750 (-17.20%) | $69,295,750 (-10.43%) |
Invested Capital Average | $61,355,000 (41.37%) | $43,401,000 (51.20%) | $28,704,750 (17.69%) | $24,391,000 (6.80%) |
Shares | 34,643,886 (0.00%) | 34,643,855 (0.13%) | 34,597,822 (0.74%) | 34,343,750 (0.20%) |
